Compounds > 3,4-dihydro-3-amino-2h-1-benzopyran
Page last updated: 2024-11-08

3,4-dihydro-3-amino-2h-1-benzopyran

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,4-dihydro-3-amino-2H-1-benzopyran: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID205709
SCHEMBL ID447509
MeSH IDM0233336

Synonyms (32)

Synonym
3,4-dihydro-2h-chromen-3-ylamine
dhabp
AKOS000184555
3,4-dihydro-2h-chromen-3-amine
chroman-3-amine
A832793
60575-19-1
EN300-57961
3,4-dihydro-2h-1-benzopyran-3-amine
3,4-dihydro-3-amino-2h-1-benzopyran
1h-1-benzopyran-3-amine, 3,4-dihydro-
3,4-dihydro-1h-1-benzopyran-3-amine
chroman-3-ylamine
AB18483
SVWDNDQOXZHBRM-UHFFFAOYSA-N
3-aminochroman
3,4-dihydro-3-amino-2h-benzopyran
3-aminochromane
SCHEMBL447509
AB56598
AB56580
(3s)-chroman-3-amine
AKOS016049003
AB01000444-01
F1907-0503
BS-13463
2h-1-benzopyran-3-amine, 3,4-dihydro-
F20762
FT-0717287
3-chromanamine
AMY7785
DTXSID20976011
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.85 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
iridium
Iridium: A metallic element with the atomic symbol Ir, atomic number 77, and atomic weight 192.22.		2.1510cobalt group element atom;
platinum group metal atom
rhodium
Rhodium: A hard and rare metal of the platinum group, atomic number 45, atomic weight 102.905, symbol Rh.. rhodium atom : A cobalt group element atom of atomic number 45.		2.1510cobalt group element atom
ruthenium
Ruthenium: A hard, brittle, grayish-white rare earth metal with an atomic symbol Ru, atomic number 44, and atomic weight 101.07. It is used as a catalyst and hardener for PLATINUM and PALLADIUM.		2.0610iron group element atom;
platinum group metal atom
2-aminotetralin
2-aminotetralin: RN given refers to parent cpd without isomeric designation; structure		2.6120tetralins
phosphites
Phosphites: Inorganic salts or organic esters of phosphorous acid that contain the (3-)PO3 radical. (From Grant & Hackh's Chemical Dictionary, 5th ed). phosphite(3-) : A trivalent inorganic anion obtained by removal of all three protons from phosphorous acid.		2.1510phosphite ion;
trivalent inorganic anion
tartaric acid
tartaric acid: RN given refers to cpd with unspecified isomeric designation. D-tartaric acid : The D-enantiomer of tartaric acid.		2.1510tartaric acidEscherichia coli metabolite
ConditionIndicatedRelationship StrengthStudiesTrials